Ever Supreme Bio Technology Co Ltd banner
E

Ever Supreme Bio Technology Co Ltd
TPEX:6712

Watchlist Manager
Ever Supreme Bio Technology Co Ltd
TPEX:6712
Watchlist
Price: 161.5 TWD Market Closed
Market Cap: NT$16.4B

Wall St Price Targets

Price Forecast
Based on 5 analysts

+3% Upside
from NT$161.5 today

Ever Supreme Bio Technology Co Ltd (6712)’s 12-month stock price forecast through October 2027 has a consensus target of NT$165.75, implying 3% upside. The forecast is based on price targets from 5 Wall Street analysts.

Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for Ever Supreme Bio Technology Co Ltd yet.

Ever Supreme Bio Technology Co Ltd Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Ever Supreme Bio Technology Co Ltd's stock price target?
Price Target
165.75 TWD

According to Wall Street analysts, the average 1-year price target for Ever Supreme Bio Technology Co Ltd is 165.75 TWD with a low forecast of 161.6 TWD and a high forecast of 173.25 TWD.

What is the Revenue forecast for Ever Supreme Bio Technology Co Ltd?
Projected CAGR
12%

The compound annual growth rate for Revenue over the next 2 years is 12%.

What is the Gross Profit forecast for Ever Supreme Bio Technology Co Ltd?
Projected CAGR
19%

The compound annual growth rate for Gross Profit over the next 2 years is 19%.

What is the Operating Income forecast for Ever Supreme Bio Technology Co Ltd?
Projected CAGR
24%

The compound annual growth rate for Operating Income over the next 2 years is 24%.

What is the Pre-Tax Income forecast for Ever Supreme Bio Technology Co Ltd?
Projected CAGR
24%

The compound annual growth rate for Pre-Tax Income over the next 2 years is 24%.

What is the Net Income forecast for Ever Supreme Bio Technology Co Ltd?
Projected CAGR
22%

The compound annual growth rate for Net Income over the next 2 years is 22%.

Back to Top